Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Schisms seen as GOP scurries

When the House voted at 3 a.m. on Friday to pass Medicare prescription drug legislation, the lawmakers addressed an urgent political problem for Republicans in the fall elections. But the pressure to pass the bill also brought to the surface tensions within the party on drug pricing issues.

House Speaker Dennis Hastert (R-Ill.) and White House political operatives worked overtime to round up votes for the legislation, arguing that passing a Medicare drug bill, even one that elicited little enthusiasm from some members, will be vital to countering Democrats.

A handful of party dissidents, sensing that the GOP's six-member margin

Read the full 1000 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE